Partnership  Bionexo and USP Hospitales in Spain

The main goal is to achieve savings of between 10 and 15%.

Bionexo and USP Hospitales have closed a strategic deal which, among other things, consists of implementing the Bionexo electronic purchasing platform, whose main objective is to achieve savings of between 10 and 15% on the total purchase volume made by the hospital group.
With a network of 35 health centers located in big Spanish cities, USP Hospitales is the largest private hospitals network in Spain.       
The implementation of the platform will start in Seville, where the group has the USP Clínica Sagrado Corazón. Its use will bring advantages to all of the suppliers of the USP Hospitales network because they will be able to work with transparency, increased productivity and better competitiveness.
The objective of the agreement to obtain the Bionexo tool is to increase productivity by means of direct and indirect cost reduction, to help purchasing departments familiarize themselves with the use of a paperless system and to increase competitiveness by enabling the users to gain access to the offers made by all the suppliers.   

The companies will develop common projects in international markets
Bionexo and USP Hospitales are putting their minds to carrying out collaborative work in their markets. In the case of Europe, with a focus on Portugal and Morocco, where USP is also present, and in Latin America, where Bionexo constantly expands its virtual community of more than 3,600 suppliers, 300 hospitals and na annual transaction volume of approximately US$ 400 million.     

USP Hospitales         

Founded in 1998 by its President and CEO, Gabriel Masfurroll, headquartered in Barcelona and keeping offices in Madrid, USP Hospitales is a privately-owned network, which is integrated and comprehensive, including services of hospital care, day surgery centers, diagnosis centers and policlinics. The business has consolidated its position as market leader as a healthcare provider, under the pillar of its own prestigious brand, which offers an alternative in healthcare services of high quality, cutting edge technology and rigorous professional ethics.      
With 3,500 employees and 2,500 doctors, the network serves annually more than two million patients and registers 180,000 visits, 70,000 surgeries, 8,500 deliveries and 200,000 emergency room services. Since it was founded the group has been developing na active investiment policy estimated at € 290 milhões and closed the last financial year of 2007 with a business volume of € 276 milhões and a gross profit (EBITDA) of € 35 million, with a forecast for 2008 of € 42,5 million (EBITDA) and € 322 million in business volume.

< back